Mizuka Kamoi Selected Research

Photophobia (Light Sensitivity)

4/2015

Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mizuka Kamoi Research Topics

Disease

7	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019 - 07/2007
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 10/2014
2	Bronchiolitis Obliterans Syndrome 11/2018 - 01/2011
1	Asthenopia (Eyestrain) 04/2015
1	Foreign Bodies (Foreign Body) 04/2015
1	Inflammation (Inflammations) 04/2015
1	Pain (Aches) 04/2015
1	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 04/2015
1	Photophobia (Light Sensitivity) 04/2015

Drug/Important Bio-Agent (IBA)

2	diquafosolIBA 11/2018 - 04/2015
2	Ophthalmic Solutions (Eye Drops)IBA 11/2018 - 04/2015
2	MucinsIBA 11/2018 - 04/2015
1	EnzymesIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	LactoferrinIBA 01/2019
1	SNARE Proteins (SNAREs)IBA 01/2017
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 01/2017
1	rebamipideIBA 04/2015
1	Rose BengalIBA 04/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2015
1	Indicators and Reagents (Reagents)IBA 10/2007
1	LipidsIBA 07/2007

Therapy/Procedure

4	Hematopoietic Stem Cell Transplantation 01/2020 - 10/2014
1	Lasers (Laser) 01/2011